Curaare Pharmaceuticals (Opc) Private Limited - Company Profile

It is a chemicals enterprise based in Kanpur, Uttar Pradesh, India, established in 2020.
2020 Kanpur, Uttar Pradesh, India Struck Off
Last Updated:
Access Report
About Curaare Pharmaceuticals (Opc) Private Limited

Curaare Pharmaceuticals (Opc) Private Limited, Engaging in basic chemical within the chemicals sector, it holds CIN: U24100UP2020OPC134568. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Maraj Khalid Kichloo (Director), Arshiya Eram Rehmani (Nominee). It is based at L G 52 Somdutt Plaza, Kanpur, Uttar Pradesh, 208001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100UP2020OPC134568

  • Registration Number

    134568

  • Incorporation Date

    14 September 2020

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 5 Months
Company report

Curaare Pharmaceuticals (Opc) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Curaare Pharmaceuticals (Opc) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Curaare Pharmaceuticals (Opc) Private Limited?
Current Directors
Name Designation Appointment Date Status
Maraj Khalid Kichloo Director 14 Sep 2020 Current
Arshiya Eram Rehmani Nominee 14 Sep 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Curaare Pharmaceuticals (Opc).

Enhance accessibility to Curaare Pharmaceuticals (Opc)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Curaare Pharmaceuticals (Opc) revenue growth over time
Curaare Pharmaceuticals (Opc) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Curaare Pharmaceuticals (Opc)?

Unlock access to Curaare Pharmaceuticals (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Curaare Pharmaceuticals (Opc)?

Curaare Pharmaceuticals (Opc) has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Curaare Pharmaceuticals (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curaare Pharmaceuticals (Opc)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Curaare Pharmaceuticals (Opc)
Recent Activity within the Organization
  • Director Appointment

    Progress on Maraj Khalid Kichloo was appointed as a Director was appointed as a Director on 14 Sep 2020 & has been associated with this company since 5 years 5 months . was documented.

  • Director Appointment

    The activity Arshiya Eram Rehmani was appointed as a Nominee was appointed as a Nominee on 14 Sep 2020 & has been associated with this company since 5 years 5 months . was completed.

  • Company Incorporation

    Progress on Curaare Pharmaceuticals (Opc) Private Limited was registered on 14 Sep 2020 with Roc Kanpur & aged 5 years 5 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Curaare Pharmaceuticals (Opc) Private Limited?

The CIN of Curaare Pharmaceuticals (Opc) Private Limited is U24100UP2020OPC134568.

Where is Curaare Pharmaceuticals (Opc) Private Limited headquartered?

Curaare Pharmaceuticals (Opc) Private Limited is headquartered at L G 52 Somdutt Plaza, Kanpur, Uttar Pradesh, 208001.

When was Curaare Pharmaceuticals (Opc) Private Limited incorporated?

Curaare Pharmaceuticals (Opc) Private Limited was incorporated on 14 September 2020.

Who are the current directors of Curaare Pharmaceuticals (Opc) Private Limited?

The current directors of Curaare Pharmaceuticals (Opc) Private Limited are

What is the primary industry of Curaare Pharmaceuticals (Opc) Private Limited?

The primary industry of Curaare Pharmaceuticals (Opc) Private Limited is Chemicals.

Is Curaare Pharmaceuticals (Opc) Private Limited a listed company?

Curaare Pharmaceuticals (Opc) Private Limited is unlisted.

What is the capital structure of Curaare Pharmaceuticals (Opc) Private Limited?

The authorized capital of Curaare Pharmaceuticals (Opc) Private Limited is ₹1.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available